Soon we’ll not be supporting this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • My watchlists
  • Help
  • Contact us

Biotech Growth Trust plc (The) (BIOG) Ordinary 25p

Sell:1,212.00p Buy:1,216.00p 0 Change: 4.00p (0.33%)
FTSE All Share:0.47%
Market closed |  Prices as at close on 24 September 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:1,212.00p
Buy:1,216.00p
Change: 4.00p (0.33%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 24 September 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:1,212.00p
Buy:1,216.00p
Change: 4.00p (0.33%)
Market closed |  Prices as at close on 24 September 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

The Biotech Growth Trust PLC is an investment trust. The Company's investment objective is to seek capital appreciation through investment in the biotechnology industry across the world. It invests in a diversified portfolio of shares and related securities in biotechnology companies. The Company will not invest more than 15%, in aggregate, of the value of its gross assets in other closed ended investment companies (including investment trusts) listed on the London Stock Exchange. The Company will not invest more than 15% of the value of its gross assets in any one individual stock at the time of acquisition. The Company will not invest more than 10% of the value of its gross assets in direct unquoted investments at the time of acquisition. OrbiMed Capital LLC is its portfolio manager. Frostrow Capital LLP is its alternative investment fund manager.

Important dates

Future events
There are no future events available.
Past events
AGM 14 July 2021 14/07/21
Final results 04 June 2021 04/06/21
Annual report 04 June 2021 04/06/21
Interim results 13 November 2020 13/11/20

General stock information

EPIC:
BIOG
ISIN:
GB0000385517
Market cap:
£510.90 million
Shares in issue:
41.67 million
Sector:
Equity Investment Instruments
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
FTSE All Share,FTSE Small Cap

Contact details

Address:
25 Southampton Buildings
LONDON
WC2A 1AL
United Kingdom
Telephone:
+44 (020) 30084910
Website:
www.biotechgt.com/

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.